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Abstract
Background: Urinary tract infections (UTI) are one of the most common infections among women worldwide.
E. coli often causes more than 75% of acute uncomplicated UTI, however, little is known about how recurrent UTIs
and indiscriminate use of antimicrobials affect the aetiology of UTIs. This study aimed to establish the aetiology of
UTI in a population of recurrent and self-medicated patients referred from pharmacies to a hospital in Hanoi,
Vietnam and to describe genotypes and antimicrobial susceptibility of the associated bacterial pathogens. The
aetiology of bacterial pathogens associated with UTI (defined as ≥ 104 CFU/ml urine) was established by
phenotypic and molecular methods. Enterococcus faecalis isolates were typed by Multi Locus Sequence Typing
(MLST), Pulsed-Field Gel Electrophoresis (PFGE) and antimicrobial susceptibility testing.
Methods: Urine samples from 276 patients suffering symptoms of urinary tract infection were collected and
cultured on Flexicult agarW allowing for detection of the most common urine pathogens. Patients were interviewed
about underlying diseases, duration of symptoms, earlier episodes of UTI, number of episodes diagnosed by
doctors and treatment in relation to UTI. All tentative E. faecalis and E. faecium isolates were identified to species
level by PCR, 16S rRNA and partial sequencing of the groEL gene. E. faecalis isolates were further characterized by
Multi Locus Sequence Typing and antimicrobial susceptibility testing.
Results: Mean age of 49 patients was 48 yrs (range was 11–86 yrs) and included 94% women. On average, patients
reported to have suffered from UTI for 348 days (range 3 days-10 years, and experienced 2.7 UTIs during the
previous year). Cephalosporins were reported the second drug of choice in treatment of UTI at the hospital.
E. faecalis (55.1%), E. coli (12.2%) and Streptococcus gallolyticus subsp. pasteurianus (8.2%) were main bacterial
pathogens. MIC testing of E. faecalis showed susceptibility to ampicillin, penicillin and vancomycin, but high-level
resistance against gentamicin (48.1%). MLST revealed 12 Sequence Types (ST) of which ST 16 made up 44.5% and
showed closely related PFGE types.
Conclusion: The different aetiology of UTI compared with reports elsewhere, where E. coli dominates, may be a
result of chronic and recurrent UTIs together with indiscriminate use of antimicrobials. The similar genotypes shown
by epidemiologically unrelated ST 16 isolates in Vietnam and elsewhere, suggest that E. faecalis ST 16 might
represent a globally distributed clone. Treatment of UTI with cephalosporins may select for E. faecalis as it is intrinsic
resistant and further studies are needed to establish the source(s) and role of E. faecalis ST 16 in acute UTI.
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Background
Urinary tract infection (UTI) represents one of the most
common bacterial infections and it is estimated that
50% of all women will experience at least one episode
of UTI during their life time [1,2]. The most frequently
isolated pathogen is E. coli making up 50% to 70% of
UTI cases [3]. Common laboratory diagnostic test for
UTI include; leucocyte esterase test, nitrite test and cul-
ture for bacterial pathogens [4,5]. Although enterococci
seem associated with a relative low percentage of
community-acquired UTI’s [6], the prevalence of entero-
cocci have increased in hospital-acquired infections in
general, and now represent a common cause of hospital-
acquired infections after E. coli and S. aureus [7]. Entero-
cocci are intrinsic resistant to a number of antimicrobials
[8] and can further easily acquire resistances which
increase their potential to cause disease and spread in
hospital environments [8]. The acquisition of high-level
gentamicin resistance by enterococci in particular repre-
sents a health problem, since gentamicin is used in com-
bination with cell-wall active compounds, i.e. ampicillin,
penicillin or vancomycin, for treatment of endocarditis
associated with enterococci [9].
Little is known about the incidence and aetiology of
UTI in Vietnam and other less developed countries. This
is partly because UTIs are most often not reportable dis-
eases and self medication is common, so many infections
are treated by patients or pharmacists alone [10]. It has
previously been described that Vietnamese women use
various forms of self-treatment to prevent and cure re-
productive tract infections which may be potentially
harmful and may favor opportunistic infections [11].
The objective of this study was to investigate the
aetiology and patient characteristics of UTI among
patients seen at a hospital in Hanoi, Vietnam, and
establish the genotypes and antimicrobial resistance
of E. faecalis, which appeared as the most common
associated pathogen.
Methods
Recruitment of patients and urine collection
All urine samples were collected from January 2008 to
January 2010 at the Military Medical University, Hospital
103 in Ha Dong, Hanoi. Nearby pharmacies were
instructed to refer patients to Hospital 103 that reported
at least one of the following clinical symptoms of UTI:
frequent urination, painful urination, hematuria, cloudy
urine, pain in pelvic area or lower back. A midstream
urine sample was collected at the hospital under super-
vision of a nurse and bacteriological culture initiated im-
mediately after collection. Based on the established
aetiology and results of antimicrobial susceptibility test-
ing, patients were informed about which antimicrobial
agent should be used for treatment. All patients were
informed orally and in writing in their own mother
tongue about the possibility to participate in the study
and withdraw at any time without explanation. After the
information was given, patients signed an approved con-
sent form. The study protocols were approved by the
ethical committee at the Hospital 103. No patients
refused to participate.
Bacterial culture of urine
Flexicult agar plates (Statens Serum Institute, Copen-
hagen, Denmark) were used for culturing urine [12].
According to the manufacturer pure cultures with ≥ 103
CFU per ml urine should be regarded positive, however,
as a conservative measure and due to the findings of un-
usual aetiology we used a definition of ≥ 104 CFU per ml
urine as a positive urine sample. The selective and indi-
cative Flexicult agar plate allows for the detection of the
10 most common pathogens associated with UTI, in-
cluding E. coli, Klebsiella spp., Enterobacter spp., and
Proteus spp. [12]. Urine samples from a total of 276
patients were poured over Flexicult plates immediately
after collection and incubated at 37°C for 18–24 hrs and
if plates showed no visible growth for another
18–24 hrs. If plates showed growth of E. coli, E. faecium
or E. faecalis in pure culture with ≥ 104 CFU per ml urine,
three individual colonies were randomly picked from the
control compartment in the plate and sub-cultured on
non-selective LB agar, Lennox plates (DifcoTM, Becton,
Dickinson and Company, Sparks, USA) which were
incubated overnight at 37°C to obtain pure cultures.
Colonies were subsequently grown overnight at 37°C in
Brain Heart Infusion broth (Oxoid, Basingstoke, Hamp-
shire, England) and stored for further characterization at
– 80°C in Cryo tubes containing 30% glycerol. The iden-
tity of the three colonies was determined to confirm
pure culture in the urine samples.
Patient questionnaire
All patients were interviewed when urine samples were
taken. Registered personal data included: age and sex as
well as self-reported underlying diseases, including
hematological disorders, respiratory infections, diar-
rhoea, diabetes, cancer, HIV/AIDS, liver cirrhosis, alco-
holism, anatomical malformations of urinary tract, and
history of nephro- or urolithiasis. Patients reporting
underlying diseases as described above as well as
hospital-acquired infections were excluded. Thus, study
subjects included those with acute, recurrent and/or
self-medicated UTI. The following clinical symptoms
were recorded: frequent urination, painful urination,
cloudy urine, blood in urine, pain in pelvic area, pain in
lower back and fever. In addition, information was
recorded about duration of symptoms, previous episodes
of UTI, number of UTI episodes during the last year
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and how many of these episodes were diagnosed by a
doctor. Finally, medical treatment of UTI before enrol-
ment in the study was registered, e.g. type of antimicro-
bial used.
PCR and 16S rRNA identification of enterococci
E. faecalis and E. faecium were identified by species-
specific PCR [13]. Isolates tentatively identified as
E. faecalis or E. faecium based on appearance on the
Flexicult agar plate, but testing negative in the E. faecalis- /E.
faecium-specific PCR (n=9), were characterized by 16S
rRNA sequence analysis (MacrogenW, Seoul, South Korea)
[14] using primers modified after [15]. Species identification
was done by BLAST search in GenBank by use of the
EzTaxon server (http://www.eztaxon.org/).
Partial sequencing of groEL
The identity of Strepcococcus gallolyticus subsp. pasteur-
ianus as shown by 16S rRNA sequence analysis was con-
firmed by partial sequencing (MacrogenW) of the groEL
gene [16] which encodes a heat-shock protein.
Sequences were assembled using CLC Main Workbench
5.2 software (CLC bio, Aarhus, Denmark) and species
identification was done by blasting the sequences in the
NCBI database (http://www.ncbi.nlm.nih.gov/). To de-
termine a more precise similarity between the obtained
sequences and the sequence of the type strain, local pair
wise sequence alignment was done, using EMBOSS
water alignment (http://www.ebi.ac.uk/).
Antimicrobial susceptibility testing
MIC were determined for 27 E. faecalis to ampicillin
(AMP, 2–32 μg/ml), penicillin (PEN, 2–32 μg/ml),
vancomycin (VAN, 1–32 μg/ml) and high-level gentami-
cin (GEN, 16–1024 μg/ml) using the SensititreW system
(Trek Diagnostics Systems, East Grindstead, England).
The following breakpoint values as proposed by
EUCAST (European Committee on Antimicrobial Sus-
ceptibility Testing; http://www.eucast.org/) were used:
AMP R > 8 μg/ml, VAN R > 4 μg/ml where as R > 128
μg/ml was used for high-level GEN resistance.
Identification of aac (6’)-Ie aph (2”)-Ia resistance gene
All strains which had a MIC ≥ 512 μg/ml and three con-
trol strains which had a MIC ≤ 16 μg/ml against genta-
micin were tested by PCR for the presence of the aac
(6’)-Ie aph (2”)-Ia gene [17] which encodes high-level
aminoglycoside resistance associated with transposons in
E. faecalis (Tn5281), Staphylococcus aureus (Tn4001)
and Staphylococcus epidermidis (Tn4031) [18].
MLST of E. faecalis
All urine isolates identified as E. faecalis (n=27) were
characterized by MLST to investigate if certain STs were
associated with UTI. One of the three E. faecalis isolates
collected from each patient was randomly selected and
characterized by full MLST sequence analyses of all
seven genes (gdh, gyd, pstS, gki, aroE, xpt, and yqil). To
confirm pure culture in the urine samples, a second iso-
late from each of 16 (28.1%) samples was typed by se-
quence analyses of the gki and yqil genes. Since the
DNA sequence of the gki and yqil genes were identical
for the two isolates characterized from individual urine
samples further sequencing were not done on isolates
from the remaining urine samples. The PCR primers
and conditions used were those described on the E. fae-
calis-MLST website (http://efaecalis.mlst.net/). Ampli-
cons were sequenced in both directions (MacrogenW).
DNA sequences were assembled and a sequence type
was assigned to each strain using CLC Main Workbench
5.2 software (CLC bio, Aarhus, Denmark) and compared
to published alleles (http://efaecalis.mlst.net/).
PFGE
All urine isolates of ST 16 (n=12) were characterized by
Pulsed-Field Gel Electrophoresis (PFGE) to determine
their clonality and degree of similarity to four E. faecalis
ST 16 strains isolated from Danish endocarditis patients
[19]. DNA was prepared directly in a solid agarose plug
(SeaKem Gold Agarose; Lonza, Basel, Switzerland) for
restriction endonuclease digestion with the enzyme
SmaI (BioLabs, New England, USA). The separations of
fragments were done on CHEF-DR III (Bio-Rad, Rich-
mond, CA, USA) at the following conditions: 6V/cm at
14°C for 20 h at a filed angel of 120°. The electrophoresis
was carried out at switch times of 2.2 to 54.4 s. Follow-
ing electrophoresis the gels were stained for 15 min in
ethidium bromide (2 mg/ml water; Sigma-Aldrich Den-
mark A/S, Brøndby, DK), then destained in water for 15




Patients seen at the Hospital 103 with urine samples
demonstrating pure cultures of ≥ 104 CFU per ml were
considered cases of UTI yielding a total of 49/276
(17.8%) positive urine samples. Among the 227 urine sam-
ples regarded as negative, coagulase-negative staphylo-
cocci appearing with small white colonies on the
Flexicult agar plate were observed in 128 samples
(56.4%), while 89 (39.2%) samples demonstrated < 104
CFU per ml and/or mixed cultures, and 10 (4.4%)
samples were sterile. Genus identification of bacterial
colonies was based on their appearance on the chromo-
genic Flexicult agar according to the manufacturer’s
instructions. Subsequently, species-specific PCR was
used to identify E. faecalis and E. faecium and 16S
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rRNA sequence analysis was used to identify Strepto-
coccus spp. and Enterococcus spp. which did not yield
an amplicon in the E. faecalis- and E. faecium specific
PCR. For Streptococcus spp. the results were confirmed
by partial sequencing of GroEL. The bacterial aetiology
could be established in 49 UTI cases (Table 1). 16S
rRNA-based identification of four S. gallolyticus subsp.
pasteurianus isolates was verified by sequencing of the
GroEL gene and alignment with the sequence of the
type strain [16] showing 100% similarity to the type
strain. Thus, the sequencing of the GroEL gene thereby
confirmed the 16S rRNA-based identification.
Characteristics of UTI patients
All 49 patients that showed ≥ 104 CFU in pure culture
per ml urine lived in the Ha Dong area in Hanoi. The
mean age was 48 yrs (range was 11–86 yrs) and
included 46 women and 3 men. On average, patients
reported to have suffered from UTI symptoms for 348
days (range 3 days-10 yrs) at the time of their enrol-
ment in the study. About one third (30.6%) of the
patients had suffered from UTI previously. On average,
patients who previously suffered from UTI had experi-
enced 2.7 episodes during the last year (range 1–15
with the majority of patients experiencing between 1
to 5 episodes) of which 60.0% of the cases were diag-
nosed by a doctor. Treatment with antimicrobials be-
fore visiting the hospital was reported by 36.7% of
UTI patients. However, only seven patients remembered
which antimicrobial they took (chloramphenicol (2),
ofloxacin (1), ampicillin (2), amoxicillin (1) and cepha-
lexin (1)). Nine (18.4%) patients had used Chinese or
Vietnamese herb medicine instead of, or in combin-
ation with antimicrobials. Specific symptoms were not
observed for the different bacterial species associated
with UTI.
MLST and PFGE typing
All isolates identified as E. faecalis (n=27) by the
species-specific PCR were characterized by MLST. A
total of 12 sequence types (ST) was identified with ST
16 making up 44.4% of the isolates (Table 2).
The relatedness of PFGE types shown by the ST 16
isolates is shown in Figure 1. PFGE patterns of ten E.
faecalis ST 16 isolated from UTI in Vietnam and four E.
faecalis ST 16 isolated from patients with endocarditis
in Denmark are shown as they represent the diversity
seen for ST 16. All isolates shared 15 DNA fragments in
their PFGE types. Five of the Vietnamese isolates and
three of the Danish isolates (lanes 7 to 14) have an add-
itional fragment of 750-kb size (Group B). Five Vietnam-
ese isolates and one Danish isolate showed PFGE types
without the 750-kb size fragment and are referred to as
group A (lanes 2 to 6 and lane 15). When guidelines of
Tenover et al. [21] are applied, all strains can be defined
as closely related based on a maximum of three frag-
ment difference.
Antimicrobial susceptibility testing and aac (6’)-Ie aph
(2”)-Ia gene
All E. faecalis isolates were susceptible to ampicillin,
penicillin and vancomycin. Resistance against high-level
gentamicin was common (48.1%). All of the high-level
gentamicin-resistant isolates contained the aac (6’)-Ie
aph (2”)-Ia gene (n=24) whereas the three isolates with a
MIC <=16 μg per ml did not harbour the gene.
Table 1 Bacterial pathogens isolated from 49 patients
with urinary tract infections (UTI) seen at a hospital in
northern Vietnam













Table 2 Distribution of MLST sequence types, and allelic







gdh gyd pstS gki aroE xpt yqil
ST 4 3 8 7 7 5 4 4 1
ST 16 12 5 1 1 3 7 7 6
ST 17 1 4 6 2 4 1 1 4
ST 93 2 25 2 15 9 23 18 26
ST 136 1 14 2 15 9 16 18 12
*ST 408 1 11 7 69 1 1 10 5
*ST 409 1 1 7 69 1 1 10 1
*ST 410 1 8 7 7 5 7 4 1
*ST 411 1 19 1 24 22 7 17 1
*ST 413 1 65 1 1 3 7 7 6
*ST 416 2 11 5 1 16 11 13 10
*ST 417 1 66 7 7 37 21 1 17
*New sequence types and allelic profiles.
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Discussion
Our findings that E. faecalis was the most common
pathogen associated with UTI are different to most pre-
vious studies where E. coli represents the main pathogen
as e.g. in the international ECO.SENS study [3]. How-
ever, it should be mentioned that the ECO.SENS study
as most other larger studies on UTI addressed only un-
complicated UTI cases. The patient characteristics found
are in accordance with other studies with respect to age
(mean age 48 yrs) and gender (94% women) [3]. How-
ever, the duration of symptoms and antimicrobial use
patterns indicate recurrent, chronic and self-medicated
UTIs. In our study, 30.6% of patients reported episodes
of UTIs during the 12-month period before they en-
rolled in the study. Thus, the patients are likely to have
suffered from recurrent UTIs and undertaken repeated
self-medication, a practice which is described as wide-
spread in Vietnam [10]. This situation may not be
unique and can be expected in other countries with
similar indiscriminate use of antimicrobials [22]. In
addition, it appears as documented elsewhere [11] that
the habit of some women to prevent and treat repro-
ductive tract infections by vaginal douching with home
prepared acidic solutions or commercial products as well
as regular use of intra-vaginal antimicrobials may change
the microflora in the genital tract and thus favor oppor-
tunistic infections. It is unknown to what extent such
practices are associated with the atypical aetiology of
UTI seen in our study. As antimicrobials are readily
available at low costs for most Vietnamese, women
suffering from acute UTI are likely to obtain antimicro-
bials for self-treatment at local pharmacies rather
than signing up to take part in our study which will take
their time and involve other people in their personal
health problems. This may explain why mainly women
suffering recurrent and complicated UTI (e.g. unknown
underlying diseases) and showing atypical aetiology par-
ticipated in our study.
About one third (37.6%) of the patients reported to
have obtained antimicrobials from local pharmacies dur-
ing a 12-month period before they were enrolled in the
study; however, only seven patients were able to remem-
ber which type of antimicrobials they used. Further,
patients were only asked if antimicrobials were used to
treat UTI and they may have received additional anti-
microbial treatments of other diseases. The first drug of
choice used at the hospital to treat UTI was amoxicillin
while the second drug of choice was cephalosporins
which will select for E. faecalis due to its intrinsic resist-
ance to cephalosporins [8]. Comparison of the preva-
lence of high-level gentamicin resistance reported from
different geographic regions indicate that our finding of
48.1% resistant E. faecalis was higher than findings of
36% in a hospital in Denmark and 22% high-level genta-
micin resistance in Greece [23,24], however, it should be
noted that only a limited number of strains were
included in our study. The gene aac (6’)-Ie aph (2”)-Ia
was found in all strains showing high-level gentamicin
resistance.
ST 16 made up 44.4% of the E. faecalis isolates recov-
ered from UTI. In the MLST data-base (http://efaecalis.
mlst.net/), ST 16 is reported as the most frequent ST of
E. faecalis recovered from clinical infections, faecal sam-
ples from hospitalized patients, healthy volunteers, and
animals in Spain and the Netherlands [25]. The geno-
types produced by PFGE confirms previous observations
that E. faecalis ST 16 show little variation in PFGE pat-
terns (1–3 fragment difference) which suggests that ST
16 is clonally distributed [25].
S. gallolyticus subsp. pasteurianus, formerly named
Streptococcus bovis biovar II/2 [26,27] was the third most
commonly isolated pathogen associated with four of the
UTIs (Table 1). This species has previously been
reported from cases of bacteraemia and endocarditis as
well as urinary tract infections [26]. Murdoch et al. [28]
reported S. bovis as an emerging pathogen associated
with infective endocarditis and as the fourth most com-
mon cause of this disease in a multinational survey from
2000 to 2005. However, reports of UTI due to this or-
ganism are rare, and future investigations are needed to
establish the role of S. gallolyticus subsp. pasteurianus in
UTI.
Conclusions
The aetiology of the UTIs seen among patients in Hanoi,
Vietnam differed from acute uncomplicated UTI seen
elsewhere as they were often recurrent, chronic and self-
medicated. E. faecalis was the main pathogen associated
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Figure 1 Pulsed-field gel electrophoresis (PFGE) of smaI
digested E. faecalis ST 16 strains. Lanes 1 and 16 are molecular
size markers. Lanes 2 to 11 show E. faecalis isolated from urinary
tract infections in Vietnam and lanes 12 to 15 show E. faecalis
isolated from Danish endocarditis patients. PFGE patterns of strains
in lanes 2 to 6 and lane 15 are referred to as type A and lanes 7
to14 as type B.
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with UTI in Vietnamese women and a possible selection
associated with indiscriminate use of antimicrobials war-
rants further investigation. ST 16 was the dominating E.
faecalis MLST type (44.4%) and their high genetic simi-
larity as shown by PFGE to ST 16 isolates recovered
from Danish endocarditis patients indicates that E. fae-
calis ST 16 is clonally distributed. Further studies are
needed to establish the source(s) and role of E. faecalis
ST 16 in UTI. The study was limited by a relative low
number of UTI cases (49). Also, the aetiology of the
UTI could have been strengthen by bacterial culture of
two consecutive collected urine samples and using a
definition of ≥ 105 CFU per ml urine as a positive urine
sample.
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